[Treatment of hemangioma in oral and maxillofacial region with pingyangmycin injection].

Abstract

OBJECTIVE:

To investigate the indication and result in hemangioma in oral and maxillofacial region with Pingyangmycin injection.

METHODS:

1282 patients (554 males and 728 females) with hemangioma in oral and maxillofacial region have been treated in our hospital during the 10-year period from May 1990 to March 1999. The patients range between 0.5-84 years old. Lip, cheek and tongue were usually involved. 1211 patients were treated with injection of Pingyangmycin(about 0.89 mg/ml) and dexamethasone (about 0.55 mg/ml), 1 time/1-2 weeks.

RESULTS:

The curative rates of cavernous hemangioma and strawberry hemangioma were 93.87% and 84.90%, but that of plexiform hemangioma was 22.22% and those of portwine stain and central hemangioma of the jaws were 0%, respectively. Serious complications associated with Pingyangmycin injection, such as pulmonary fibrosis were not seen.

CONCLUSION:

Injection of Pingyangmycin is selective primary method for cavernous and strawberry hemangioma treatment.

• Authors: C Wang, Q Gao, F Fu, Y Wen, X Dai, H Gong, X Lu
• Journal: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology (Hua Xi Kou Qiang Yi Xue Za Zhi) Vol. 18 Issue 5 Pg. 317-9 (Oct 2000) ISSN: 1000-1182 [Print] China
• PMID: 12539650 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antibiotics, Antineoplastic
• Bleomycin
• zhengguangmycin

Topics

• Adolescent
• Adult
• Aged
• Antibiotics, Antineoplastic (administration & dosage, therapeutic use)
• Bleomycin (administration & dosage, analogs & derivatives)
• Child
• Child, Preschool
• Facial Neoplasms (drug therapy)
• Female
• Hemangioma, Cavernous (drug therapy, pathology)
• Humans
• Infant
• Infant, Newborn
• Injections, Intralesional
• Jaw Neoplasms (drug therapy)
• Male
• Middle Aged
• Mouth Neoplasms (drug therapy)